Biohaven appoints John Yetimoglu to board, effective Aug 6, 2026

Biohaven Ltd.

John Yetimoglu appointed to Biohaven board effective Aug 6, 2026; term expires at 2027 annual meeting.
Granted options with aggregate grant date fair value of $713,875; vest 25% on grant, 25% annually over 3 years.
Receives $57,000 annual retainer for director and committee service; joins Nominating and Governance Committee.
No family relationships or reportable transactions with company per Item 404(a).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.